Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1904768

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1904768

Intrauterine Devices Market Size, Share, and Growth Analysis, By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing25-34 years), By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Intrauterine Devices Market size was valued at USD 3.36 Billion in 2024 and is poised to grow from USD 3.49 Billion in 2025 to USD 4.7 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The intrauterine devices (IUD) market is experiencing significant growth due to various driving factors, including the rising incidence of unplanned pregnancies and unsafe abortions, along with heightened awareness of these contraceptive options. Demand is bolstered by government initiatives and key players investing in research to develop advanced devices. The trend of planned delayed pregnancies, especially in the U.S., is facilitating access to reproductive health services. However, challenges such as limited awareness regarding IUD use, potential side effects like pain and irregular bleeding, and premature removal hinder market expansion. In contrast, increasing disposable incomes and a growing focus on healthy lifestyles in emerging economies present opportunities. Favorable regulations and ongoing technological advancements are anticipated to further enhance the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intrauterine Devices Market Segments Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Intrauterine Devices Market

The rising awareness surrounding family planning and the necessity for reliable contraception methods has significantly fueled the growth of the intrauterine devices market. As more individuals and healthcare professionals acknowledge the advantages of long-lasting birth control solutions, the popularity and demand for IUDs have surged. This shift in perception emphasizes the importance of effective reproductive health options, leading to greater acceptance and utilization of intrauterine devices. Consequently, the market is experiencing robust growth, driven by the collective focus on empowering individuals to make informed choices about their reproductive health and family planning strategies.

Restraints in the Intrauterine Devices Market

The market for intrauterine devices faces significant constraints due to the rigorous regulatory frameworks governing these medical products. Ensuring compliance with safety and efficacy standards can prove to be a complex task for manufacturers, often requiring extensive documentation and approval processes. This regulatory burden not only poses challenges for existing players but also serves as a barrier to new entrants seeking to establish themselves in the market. Consequently, these stringent requirements can impede overall market growth, as potential competitors may be deterred from pursuing opportunities in the intrauterine device sector.

Market Trends of the Intrauterine Devices Market

The Intrauterine Devices (IUDs) market is experiencing a notable upward trend driven by the rising incidence of unplanned pregnancies and an increasing awareness of reproductive health. Hormonal IUDs are particularly gaining traction for their dual benefits of effective contraception and management of menstrual symptoms, including severe cramps and heavy bleeding. Initiatives by health organizations to promote family planning and educate the public on the advantages of various contraceptive methods further enhance market growth. This trend is also reflected in the growing acceptance of IUDs among nulliparous women and adolescents, thanks to their safety profile, which minimizes risks associated with ectopic pregnancies and reproductive health issues.

Product Code: SQMIG35A2678

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2026-2033)

  • Nonhormonal: Copper-containing IUD
  • Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2026-2033)

  • 25-34 years
  • 35-44 years
  • Above 44 years
  • 15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2026-2033)

  • Hospital
  • Gynecology Clinics
  • Community Health Care Centers
  • Others

Global Intrauterine Devices Market Size by End User & CAGR (2026-2033)

  • Hospitals
  • Clinics
  • Community Health Care Centres
  • Others

Global Intrauterine Devices Market Size by Region & CAGR (2026-2033)

  • North America, (by Type, by Age Group, by Distribution Channel, by End User)
    • US
    • Canada
  • Europe, (by Type, by Age Group, by Distribution Channel, by End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • AbbVie Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DKT International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EUROGINE, S.L.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mona Lisa N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OCON Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pregna International Limited.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prosan International BV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SMB Corporation of India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ANI Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan NV (Viatris)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Melbea AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Contrel Europe
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Durbin
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gima S.p.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HLL Lifecare Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meril Life Sciences Pvt. Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mona Lisa N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!